Table 2.
Control | Time | N | SMD | CIL | CIU | P | I2 (%) | PIL | PIU | GRADE confidence |
---|---|---|---|---|---|---|---|---|---|---|
Passive | Post-int | 13 | −0.28 | −0.36 | −0.20 | 0.000 | 0.00 | −0.36 | −0.20 | Moderate |
Passive | 1–6m | 13 | −0.32 | −0.41 | −0.24 | 0.000 | 0.00 | −0.41 | −0.24 | High |
Passive | 6+m | 13/3a | −0.29 | −0.40 | −0.18 | 0.000 | NA | −0.41 | −0.16 | Low |
Active | Post-int | 4 | −0.05 | −0.35 | 0.26 | 0.673 | 36.19 | −0.68 | 0.59 | Very low |
Active | 1–6m | 4 | 0.03 | −0.20 | 0.25 | 0.735 | 0.00 | −0.28 | 0.33 | Very low |
Random-effects meta-analyses using the restricted maximum-likelihood method (two-sided tests with no adjustment for multiple comparisons). The primary outcome is in bold.
1–6m, follow-up within 1–6 months post-intervention; 6+m, follow-up over 6 months post-intervention; CIL, 95% confidence interval lower; CIU, 95% confidence interval upper; NA, not applicable; PIL, prediction interval lower; PIU, prediction interval upper.
aMultivariate meta-analysis: number of studies that contributed to the result/number of studies that measured the outcome.